Chengdu Climb Pharmaceutical Technology Co.,Ltd.,established in 2013, is a high-tech enterprise who engages in R&D, production and sales of API and intermediates. Adhering to the "create high-quality pharmaceutical products" mission, Climb gather a large number of related industries cutting-edge talents, and continuously develop quality products of high technical barriers, high difficulty and high added value.Variety of areas involve anti infection, cardiovascular system, anti-tumor, nervous system, gastrointestinal digestive system, etc.. Climb's R&D center locates in “Tianfu Science Technology Industry Park”, And Climb also built two manufacturing sites in Wenjiang and Qionglai as per GMP standard.We can provide high quality products to customers in different scopes from gram, kilogram to ton, also can provide customized products and high-quality technical services for domestic and oversea pharmaceutical groups.Up to now,our products exported to more than ten countries such as:Portugal, Germany, Croatia,Columbia,Japan,Korea,India and Bangladesh. For the high risk pharmaceutical manufacturing industry, product quality determines the competitiveness of enterprises. We establish a complete set of GMP quality management system through the concerted efforts and strictly enforced. We passed the audit of decades of global famous enterprises . Integrity, pragmatic, efficient and innovative are shared set of values for the whole enterprise. With the marketing strategy“Better quality for same product, Better price for same quality, Better service for same price “, we are willing to sincerely cooperate with customers at home and abroad, hand in hand.
Year Established: 2013
Total Assets(USD): choose not to disclose
Total Number of Staff: 50 to 59
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Production capacity,Contract Manufacturing,Quality Service
Business Type: Manufacturer,Trading Company
Annual Turnover(USD) : choose not to disclose
Main Sales Markets : Western Europe,Asia,Middle East
Subscribe to the latest newsletter of Virtual Expo Connect